[PRESS RELEASE] Sweetch Health Raises $3.5M to Deploy Large Scale Personalized Diabetes Prediction and Prevention Platform

Jerusalem, Israel —April 7, 2016—  Sweetch Health, which has developed a “digital vaccine” for diabetes, has raised $3.5 million in a Series A round led by Philips, a leading health technology company, and OurCrowd, a leading equity crowdfunding platform.  Participation from prior investors also included Pontifax L.P. and Lionbird L.P.